06:31:09 EDT Fri 14 May 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:LCI from 2020-05-15 to 2021-05-14 - 30 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-05-05 16:15U:LCINews ReleaseLannett Announces Fiscal 2021 Third-Quarter Financial Results
2021-04-28 06:53U:LCINews ReleaseLannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 5
2021-04-22 16:15U:LCINews ReleaseLannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan Facility
2021-04-09 06:52U:LCINews ReleaseLannett Announces Pricing Of $350 Million Senior Secured Notes Due 2026
2021-04-06 07:21U:LCINews ReleaseLannett Announces Offering Of $350 Million Senior Secured Notes Due 2026
2021-04-01 08:30U:LCINews ReleaseLannett Submits ANDA For Generic ADVAIR DISKUS ®
2021-03-18 17:25U:LCINews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI
2021-03-12 06:25U:LCINews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI
2021-03-10 06:52U:LCINews ReleaseLannett Development Of Biosimilar Insulin Glargine Product Continues To Advance
2021-03-03 03:00U:LCINews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI
2021-02-19 01:15U:LCINews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI
2021-02-09 06:53U:LCINews ReleaseLannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
2021-02-08 06:52U:LCINews ReleaseLannett Begins Marketing Chlorpromazine Hydrochloride Tablets
2021-02-03 16:15U:LCINews ReleaseLannett Announces Fiscal 2021 Second-Quarter Financial Results In Line Or Above Expectations
2021-01-27 06:52U:LCINews ReleaseLannett To Report Fiscal 2021 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 3
2020-12-07 16:15U:LCINews ReleaseLannett Announces New $30 Million Revolving Credit Facility
2020-11-30 06:52U:LCINews ReleaseLannett Pays Off, In Full, Remaining Term A Loans
2020-11-04 16:15U:LCINews ReleaseLannett Announces Fiscal 2021 First-quarter Financial Results; Affirms Guidance
2020-11-03 06:52U:LCINews ReleaseLannett Launches Authorized Generic of Tirosint ® (Levothyroxine Sodium Capsules)
2020-10-28 06:53U:LCINews ReleaseLannett To Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call On Wednesday, November 4
2020-08-26 16:15U:LCINews ReleaseLannett Announces Fiscal 2020 Fourth-Quarter, Full-Year Financial Results
2020-08-19 06:52U:LCINews ReleaseLannett To Report Fiscal 2020 Fourth-Quarter, Full-Year Financial Results, Host Conference Call On Wednesday, August 26
2020-08-17 16:30U:LCINews ReleaseLannett Announces Notice Of Proposed Settlement And Dismissal With Prejudice Of Derivative Action
2020-08-17 06:52U:LCINews ReleaseLannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent ® Diskus ®
2020-08-03 06:53U:LCINews ReleaseLannett Announces Launch Of FDA Approved Levothyroxine Tablets
2020-07-27 06:52U:LCINews ReleaseLannett To Launch Levorphanol Tablets
2020-07-23 06:52U:LCINews ReleaseLannett Launches Mexiletine HCl Capsules
2020-07-16 06:55U:LCINews ReleaseLannett And Cediprof Announce Exclusive Distribution Agreement For An Approved Levothyroxine
2020-07-13 06:52U:LCINews ReleaseLannett Announces Restructuring, Cost Reduction Initiatives
2020-06-11 06:52U:LCINews ReleaseLannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting